Astrazeneca ADR Aktie
-
Deine Einschätzung
Astrazeneca ADR Aktie
Was spricht für und gegen Astrazeneca ADR in den nächsten Jahren?
Pro
Kontra
Rendite von Astrazeneca ADR im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Astrazeneca ADR | - | - | - | - | - | - | - |
| GSK plc ADR | 1,21 % | -2,88 % | 19,10 % | 40,28 % | 20,81 % | 53,03 % | 44,29 % |
| Bayer AG ADR | -6,42 % | -12,07 % | -12,82 % | 83,78 % | 15,91 % | -31,54 % | -19,05 % |
| UCB S.A. | 1,01 % | -9,41 % | -3,98 % | 40,69 % | 5,81 % | 204,41 % | 206,12 % |
Kommentare
News
After a Near 50% Drop, Tempus AI Could Be Ripe for a Rebound
Since going public in mid-2024, shares of healthcare and life science services company Tempus AI (NASDAQ: TEM) have gone on a wild rollercoaster ride. The firm’s initial public offering price
A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH
More than just a financial check-up, earnings for companies in the healthcare sector offer a key window for investors into a firm's pipeline and development progress. Even well-established, stable
1 Quantum Computing Stock to Buy that Could Soar in 2026
Quantum computing is moving from the theoretical to the commercially applicable, but only one company has achieved 99.99% two-qubit gate fidelity (a measure of results accuracy). That company is



